| Literature DB >> 29579142 |
Abstract
Entities:
Mesh:
Year: 2018 PMID: 29579142 PMCID: PMC5888957 DOI: 10.1093/ageing/afx192
Source DB: PubMed Journal: Age Ageing ISSN: 0002-0729 Impact factor: 10.668
Levels of evidence (according to the NHMRC* designation [6])
| I | Evidence obtained from a systematic review of all relevant randomised controlled trials |
| II | Evidence obtained from at least one properly designed randomised controlled trial |
| III-1 | Evidence obtained from well-designed pseudo-randomised controlled trials (alternate allocation or some other method) |
| III-2 | Evidence obtained from comparative studies with concurrent controls and allocation not randomised (cohort studies), case-controlled studies or interrupted time series with a control group |
| III-3 | Evidence obtained from comparative studies with historical control, two or more single-arm studies, or interrupted time series without a parallel control group |
| IV | Evidence obtained from case series, either post-test or pre-test and post-test |
*[6] A guide to the development, implementation and dissemination of clinical practice guidelines. Commonwealth of Australia, Canberra. Reproduced by permission.